Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.
Public ClinicalTrials.gov record NCT04371861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Multi-center, Observational, Post-market Study to Assess the Safety and Procedural Success of Performing Transradial Access for Treatment of Atherosclerotic Lesions in the Lower Extremities.
Study identification
- NCT ID
- NCT04371861
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Terumo Medical Corporation
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Peripheral Artery Treatment Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2020
- Primary completion
- Aug 27, 2021
- Completion
- Jun 29, 2022
- Last update posted
- Jul 9, 2023
2020 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD | La Jolla | California | 92037 | — |
| Northside Hospital | St. Petersburg | Florida | 33709 | — |
| Cardiovascular Institute of the South | Lafayette | Louisiana | 70503 | — |
| Mercy Hospital | Springfield | Missouri | 65804 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Sorin Medical, Inc. | New York | New York | 10065 | — |
| University Hospitals | Cleveland | Ohio | 44106 | — |
| Ascension Seton Hays Hospital | Kyle | Texas | 78640 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04371861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04371861 live on ClinicalTrials.gov.